Dr Sara Ghorashian

Sara Ghorashian is Consultant Paediatric Haematologist at Great Ormond Street Hospital for Children, London, UK and Honorary Senior Lecturer at UCL. After receiving her medical degree from the University of Oxford, Dr Ghorashian undertook a PhD in TCR gene engineering of therapeutic T cells at the University College London Institute of Immunity and Infection. In 2014 she became Principal Clinical Research Associate at the UCL Institute of Child Health, acting as lead scientist of the CARPALL study, utilising low-avidity CD19 CAR-T cells for paediatric ALL before assuming her current position in early 2018. Dr Ghorashian’s research focuses on T-cell immunobiology and the use of cellular immunotherapies for children with haematological malignancies, having worked to translate CD19-targeted CAR-T cells from the laboratory to the clinic. She is co-/sub-investigator on CAR-T cell studies in paediatric patients and is involved in the implementation of new studies to improve outcomes for children with high-risk or relapsed acute leukaemia.